Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc.（SLNO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
slno · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年5月20日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$107
Consensus
$80.00
+50.9% upside
Low
$53.00
Median: $80 · Last Close: $53.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$80.00
50.9% upside
High Target
$107
101.8%
Low Target
$53
-0.0%
Current Price
$53.01
as of today
Based on analyst price targets, the SLNO stock price prediction for the next 12 months ranges from $53 to $107. The consensus SLNO price forecast of $80.00 implies 50.9% upside from the current price of $53.01.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $52.81 | ↓ 0.38% |
1-day model range: $52.8–$52.82. Peak: $52.82 (-0.38%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $57 | +6.7% |
| 2028 | $59 | +11.0% |
| 2029 | $60 | +13.7% |
| 2030 | $61 | +15.4% |
| 2031 | — | +16.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SLNO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-17 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-04-08 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-04-07 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2026-04-07 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-04-06 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2026-03-18 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-27 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-26 | TD Cowen | Maintains | Buy→Buy |
| 2026-01-20 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Soleno Therapeutics, Inc. (SLNO) stock. Of the recent 46 rating actions, 0 were upgrades and 5 were downgrades. 13 analysts currently cover SLNO.
分析师推荐趋势
SLNO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$462M
↓ 53.0% YoY
Revenue Next Year
$688M
↑ 48.9% YoY
EPS This Year
$3.81
EPS Next Year
$6.14
↑ 61.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast SLNO EPS of $3.81 for the current fiscal year, based on estimates from 7 analysts. The SLNO revenue forecast is $462M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SLNO 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SLNO 的共识目标价为 $80.00（+50.9% 上行空间），分析师共识为 Buy。
SLNO 的短期预测（明日）为 $52.81（-0.38%）。 SLNO 对 2027 年的股价预测均值为 $57。 SLNO 对 2030 年的预测区间为 $61–$61。
Soleno Therapeutics, Inc. 在 NASDAQ 上市，代码 SLNO。SLNO 在 2027 年的整体展望偏积极，在覆盖分析师中约 62% 对应 Buy 共识。
常见问题
SLNO 预测 · 8 个问题根据 13 位华尔街分析师，SLNO 的 12 个月平均目标价为 $80.00，最高 $107.00、最低 $53.00。若有图表，中位目标价可在上方查看。相对当前价 $53.01，隐含约 +50.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.